IP Library Patent Application 12969393
Patent Application
App. No. 12/969,393

SIRNA AND METHODS OF MANUFACTURE

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/969,393
Abstract

Double-stranded RNA of about 19 to about 25 nucleotides in length capable of regulating gene expression by RNA interference is provided. Such double-stranded RNA are particularly useful for treating disease or conditions associated with a target mRNA or gene. Methods of manufacture and methods of use of the double-stranded RNA are also provided.

Claims (20)

1 . A method of preparing a double-stranded RNA molecule comprising

(a) synthesizing a first set of two or more RNA sub-strands, wherein the combined length of the first set of sub-strands is from about 19 to about 25 nucleotides,

(b) synthesizing a second set of two or more RNA sub-strands, wherein the combined length of the second set of sub-strands is from about 19 to about 25 nucleotides;

(c) combining the synthesized first and second set of RNA sub-strands under conditions, wherein a double-stranded RNA molecule is formed

2 . The method according to claim 1 , wherein the RNA strands are chemically synthesized.

3 . The method according to claim 1 , wherein the RNA strands are enzymatically synthesized.

4 . The method of claim 1 , wherein the double-stranded RNA molecule comprises a single double stranded region and single stranded regions of about 1 to about 5 nucleotides at the 3′ ends of at least one of the strands of the double-stranded RNA molecule.

5 . The method of claim 1 , wherein both strands of the double-stranded RNA molecule each have a 3′-overhang from about 1 to about 5 nucleotides.

6 . The method of claim 1 , wherein both strands of the double-stranded RNA molecule each have a 3′-overhang of about 2 nucleotides.

7 . The method of claim 1 , wherein each strand has a length from 20-22 nucleotides.

8 . The method of claim 1 , wherein the double-stranded RNA molecule comprises at least one sugar-modified nucleotide, wherein the 2′-OH group of said sugar-modified nucleotide is replaced by a group selected from H, OR, R, halo, SH, SR, NH 2 , NHR, N(R) 2 or CN, wherein R is C 1 -C 6 alkyl, alkenyl or alkynyl and halo is F, C, Br or I.

9 . The method of claim 1 , wherein the double stranded RNA molecule comprises at least one backbone-modified nucleotide containing a phosphorothioate group.

10 .- 18 . (canceled)

19 . A method of preparing a double-stranded RNA molecule comprising

(a) synthesizing a first set of two or more RNA sub-strands, wherein the combined length of the first set of sub-strands is 25 or fewer nucleotides,

(b) synthesizing a second set of two or more RNA sub-strands, wherein the combined length of the second set of sub-strands is 25 or fewer nucleotides;

(c) combining the synthesized first and second set of RNA sub-strands under conditions, wherein a double-stranded RNA molecule is formed.

20 . The method of claim 19 , wherein the double-stranded RNA molecule comprises a single double stranded region and single stranded regions of about 1 to about 5 nucleotides at the 3′ ends of at least one of the strands of the double-stranded RNA molecule.

21 . The method of claim 20 , wherein each strand has a length from 20-22 nucleotides.

22 .- 24 . (canceled)

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 29, 2015
From: OPKO PHARMACEUTICALS, LLC
To: RXI PHARMACEUTICALS CORPORATION
Reel/Frame 035527/0144 →
CHANGE OF NAME Recorded Oct 3, 2012
From: OPKO OPHTHALMICS, LLC.
To: OPKO PHARMACEUTICALS, LLC.
Reel/Frame 029068/0529 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 15, 2010
From: ENDEJANN, N. NICOLE; REICH, SAMUEL JOTHAM
To: EXEGENICS, INC., D/B/A OPKO HEALTH, INC.
Reel/Frame 025507/0742 →
CHANGE OF NAME Recorded Dec 15, 2010
From: OPKO HEALTH, INC.
To: OPKO OPHTHALMICS, LLC
Reel/Frame 025507/0804 →